You are here
Home 🌿 Marijuana Business News 🌿 Canada's Wayland Group strikes medicinal marijuana deal in the NT 🌿Canada's Wayland Group strikes medicinal marijuana deal in the NT

Wayland Group, formerly known as Maricann, has agreed to make an initial payment of $5.5 million ($4.8 million Canadian dollars), followed by a second payment of $27.5 million following certain milestones being achieved, including Tropicann obtaining a license to cultivate cannabis in Australia.
Wayland CEO Ben Ward said in a statement that the Northern Territory was "the ideal location for our new Asia Pacific hub".
"The location provides Wayland with ideal climate conditions in a globally respected and sovereign country with a large and fast emerging market of over 250 million people just four hours north," he said.
"This acquisition accelerates Wayland's growth strategy in becoming a truly global cannabis company."
Wayland's statement said the payments were "conditional on receipt of applicable stock exchange approval, approval of holders of at least two-thirds of the company's outstanding debentures and any other applicable approvals".
NT Government excited by marijuana development
Northern Territory Chief Minister Michael Gunner said the NT Government was working to give Wayland's proposal Major Project Status.
"We're very excited to see a potential new industry in the Northern Territory," he told the ABC.
"We are working with [Wayland Group] around Major Project Status, they are looking to purchase private sector land.
"They're looking anywhere from 300 to 1,000 hectares to grow medicinal marijuana and starting cropping from next year.
"So this is incredibly exciting, we know this is a growth market for Australia and we're working with them [Wayland] on that investment for local jobs."
The ABC has requested an interview with Wayland Group and also Tropicann, which is believed to be a new company, formed in October this year by members of the Canaris family.
On its website, Wayland describes itself as "a vertically integrated producer and distributor of cannabis for medical purposes".
The company was founded in 2013 and has headquarters in Canada and Germany, with production facilities in Ontario (Canada) where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada.
The company also has production operations in Dresden in Germany and Regensdorf in Switzerland.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.